Lifecore Biomedical Stock Market Value
| LFCR Stock | 5.76 0.16 2.86% |
| Symbol | Lifecore |
Lifecore Biomedical Company Valuation
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifecore Biomedical. If investors know Lifecore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifecore Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Revenue Per Share | Quarterly Revenue Growth 0.08 | Return On Assets | Return On Equity |
The market value of Lifecore Biomedical is measured differently than its book value, which is the value of Lifecore that is recorded on the company's balance sheet. Investors also form their own opinion of Lifecore Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Lifecore Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifecore Biomedical's market value can be influenced by many factors that don't directly affect Lifecore Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifecore Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifecore Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifecore Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lifecore Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifecore Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifecore Biomedical.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Lifecore Biomedical on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Lifecore Biomedical or generate 0.0% return on investment in Lifecore Biomedical over 30 days. Lifecore Biomedical is related to or competes with Shuttle Pharmaceuticals, Tilray, Kamada, Cumberland Pharmaceuticals, Ironwood Pharmaceuticals, Journey Medical, and Akanda Corp. Lifecore Biomedical is entity of United States More
Lifecore Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifecore Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifecore Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 28.39 | |||
| Value At Risk | (7.10) | |||
| Potential Upside | 8.11 |
Lifecore Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifecore Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifecore Biomedical's standard deviation. In reality, there are many statistical measures that can use Lifecore Biomedical historical prices to predict the future Lifecore Biomedical's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | (0.09) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lifecore Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lifecore Biomedical Backtested Returns
Lifecore Biomedical has Sharpe Ratio of -0.0756, which conveys that the firm had a -0.0756 % return per unit of risk over the last 3 months. Lifecore Biomedical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lifecore Biomedical's Standard Deviation of 4.54, insignificant risk adjusted performance, and Mean Deviation of 3.2 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.79, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lifecore Biomedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lifecore Biomedical is expected to be smaller as well. At this point, Lifecore Biomedical has a negative expected return of -0.34%. Please make sure to verify Lifecore Biomedical's maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Lifecore Biomedical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.03 |
Very weak reverse predictability
Lifecore Biomedical has very weak reverse predictability. Overlapping area represents the amount of predictability between Lifecore Biomedical time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifecore Biomedical price movement. The serial correlation of -0.03 indicates that only 3.0% of current Lifecore Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Lifecore Biomedical lagged returns against current returns
Autocorrelation, which is Lifecore Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lifecore Biomedical's stock expected returns. We can calculate the autocorrelation of Lifecore Biomedical returns to help us make a trade decision. For example, suppose you find that Lifecore Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lifecore Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lifecore Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lifecore Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lifecore Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Lifecore Biomedical Lagged Returns
When evaluating Lifecore Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lifecore Biomedical stock have on its future price. Lifecore Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lifecore Biomedical autocorrelation shows the relationship between Lifecore Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Lifecore Biomedical.
Regressed Prices |
| Timeline |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.